Abstract
Metabolism-dependent inhibition (MDI) of cytochrome P450 is usually assessed in vitro by examining whether the inhibitory potency of a drug candidate increases following a 30-min incubation with human liver microsomes (HLM). To augment the IC50 shift, many researchers incorporate a dilution step whereby the samples, after being pre-incubated for 30 min with a high concentration of HLM (with and without NADPH), are diluted prior to measuring P450 activity. In the present study, we show that the greater IC50 shift associated with the dilution method is a consequence of data processing. With the dilution method, IC50 values for direct-acting inhibitors vary with the dilution factor unless they are based on the final (post-dilution) inhibitor concentration whereas the IC50 values for MDIs vary with the dilution factor unless they are based on the initial (pre-dilution) concentration. When the latter data are processed on the final inhibitor concentration, as is commonly done, the IC50 values for MDI (shifted IC50 values) decrease by the magnitude of the dilution factor. The lower shifted IC50 values are a consequence of data processing, not enhanced P450 inactivation. In fact, for many MDIs, increasing the concentration of HLM actually leads to considerably less P450 inactivation because of inhibitor depletion and/or binding of the inhibitor to microsomes. A true increase in P450 inactivation and IC50 shift can be achieved by assessing MDI by a non-dilution method and by decreasing the concentration of HLM. These results have consequences for the conduct of MDI studies and the development of cutoff criteria.
- CYP inhibition
- cytochrome P450
- drug development
- drug-drug interactions
- human CYP enzymes
- inactivation
- inhibition
- liver microsomes
- mechanism-based inhibition
- suicide inhibition
- Received February 8, 2011.
- Accepted April 27, 2011.
- The American Society for Pharmacology and Experimental Therapeutics